|
Video: What is a Stock Split?
|
|
Assertio Therapeutics is a pharmaceutical company. Co.'s primary marketed products include: INDOCIN® (indomethacin) Suppositories and INDOCIN® (indomethacin) Oral Suspension, which is a suppository form and oral solution of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), approved for moderate to severe rheumatoid arthritis, ankylosing spondylitis and osteoarthritis; CAMBIA® (diclofenac potassium for oral solution), which is a prescription NSAID indicated for the acute treatment of migraine attacks in adults; and Otrexup® (methotrexate) injection, used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis. According to our ASRT split history records, Assertio Holdings has had 1 split. | |
|
Assertio Holdings (ASRT) has 1 split in our ASRT split history database. The split for ASRT took place on May 18, 2021. This was a 1 for 4 reverse split, meaning for each 4 shares of ASRT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 250 share position following the split.
When a company such as Assertio Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ASRT split history from start to finish, an original position size of 1000 shares would have turned into 250 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Assertio Holdings shares, starting with a $10,000 purchase of ASRT, presented on a split-history-adjusted basis factoring in the complete ASRT split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$57.12 |
|
End price/share: |
$0.87 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-98.48% |
|
Average Annual Total Return: |
-34.19% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$152.20 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
05/18/2021 | 1 for 4 |
|
|